Stocks
Cardiovascular Systems () R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | ||||
| R&D/CAPEX, % | 941.3% | 1 061% | 1 038% | 870.1% | 805.4% | ||||
| Changes by years, y/y, % | +69pp | +120pp | -23pp | -1 038pp | -7.1% | ||||
Cardiovascular Systems. R&D/CAPEX, %
Cardiovascular Systems. R&D/CAPEX, changes, pp
Cardiovascular Systems () R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2022Q1 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
| R&D/CAPEX, % | 1 140% | 877.3% | 1 316% | 467.5% | 805.4% | |||
| Changes by years, y/y, % | -800pp | -578pp | +104pp | |||||
| Changes by quarters, q/q, % | -671pp | -263pp | +439pp | -849pp | ||||
